NewGenIvf director exercises 56,851 options

NewGenIvf Group director Siu Wing Fung Alfred exercised vested stock options to acquire 56,851 Class B Ordinary Shares at $0.0001 per share on June 4, 2026.

Rhea-AI Filing Summary

NewGenIvf Group director Siu Wing Fung Alfred exercised vested stock options to acquire 56,851 Class B Ordinary Shares at $0.0001 per share on June 4, 2026. The exercise, under the 2024 Share Incentive Plan and an employee option agreement, raised his direct holdings to 56,881 shares after the transaction.

Insider Trade Summary

Exercise: 56,851 shares

Exercise 1 txn

Insider Siu Wing Fung Alfred

Role Director

Type	Security	Shares	Price	Value
Exercise	Class B Ordinary Shares	56,851	$0.0001	$5.69

Holdings After Transaction: Class B Ordinary Shares — 56,881 shares (Direct)

Footnotes (1)

1. F1. The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026.

Key Figures

Options exercised: 56,851 shares Exercise price: $0.0001 per share Shares held after: 56,881 shares +3 more

6 metrics

Options exercised 56,851 shares Class B Ordinary Shares acquired on June 4, 2026

Exercise price $0.0001 per share Price for exercised stock options

Shares held after 56,881 shares Direct Class B Ordinary Shares following transaction

Option agreement date May 4, 2026 Date of employee share option agreement

Acceleration date May 26, 2026 Independent directors resolved to accelerate options

Exercise date June 4, 2026 Date options were exercised by the director

Key Terms

Class B Ordinary Shares, stock options, 2024 Share Incentive Plan, employee share option agreement, +1 more

5 terms

Class B Ordinary Shares financial

"acquire 56,851 Class B Ordinary Shares at $0.0001 per share"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

stock options financial

"exercised vested stock options to acquire 56,851 Class B Ordinary Shares"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

2024 Share Incentive Plan financial

"The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan"

employee share option agreement financial

"the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person"

independent directors financial

"The options were accelerated by resolution of the independent directors of the Board of Directors"

Members of a company’s board who do not have significant business, family, or financial ties to the company and are not part of its management; they are chosen to provide impartial oversight of strategy, financial reporting, executive pay and risk. They matter to investors because independent directors act like an objective referee, helping ensure decisions favor shareholders’ long-term interests rather than insiders, which can strengthen trust and reduce the chance of mismanagement or conflicts of interest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NewGenIvf (NIVF) report for Siu Wing Fung Alfred?

NewGenIvf reported that director Siu Wing Fung Alfred exercised vested stock options to acquire 56,851 Class B Ordinary Shares on June 4, 2026. The options were granted under the company’s 2024 Share Incentive Plan as part of his compensation package.

How many NewGenIvf (NIVF) shares does Siu Wing Fung Alfred hold after this Form 4?

After the option exercise, Siu Wing Fung Alfred directly holds 56,881 Class B Ordinary Shares. This reflects the addition of 56,851 shares acquired through vested stock options, according to the reported holdings following the June 4, 2026 transaction.

What was the exercise price of the NewGenIvf (NIVF) stock options?

The vested stock options were exercised at $0.0001 per Class B Ordinary Share. This nominal exercise price is typical for employee incentive options and was set under NewGenIvf’s 2024 Share Incentive Plan and the related employee option agreement.

Were NewGenIvf (NIVF) options accelerated before this insider exercise?

Yes. The options exercised by Siu Wing Fung Alfred were accelerated by a resolution of the independent directors on May 26, 2026. This acceleration allowed earlier vesting and enabled him to exercise the options on June 4, 2026.

Under which plan were the NewGenIvf (NIVF) options granted to Siu Wing Fung Alfred?

The options were granted under NewGenIvf Group Ltd’s 2024 Share Incentive Plan. They were documented in an employee share option agreement dated May 4, 2026 between the company and Siu Wing Fung Alfred, as described in the Form 4 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 11:14 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siu Wing Fung Alfred

(Last) (First) (Middle)

C/O 1/F, PIER 2, CENTRAL

(Street)

HONG KONG

(City) (State) (Zip)

HONG KONG

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Ordinary Shares	06/04/2026		M		56,851	A(1)	$0.0001	56,881	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026.

	/s/ Siu Wing Fung Alfred	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)